- Home
- KMI vs SNN Comparison
KMI vs SNN Comparison
Compare KMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMI | SNN |
|---|---|---|
| Founded | 1936 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.8B | 12.3B |
| IPO Year | 2010 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KMI | SNN |
|---|---|---|
| Price | $31.37 | $28.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 2 |
| Target Price | $33.69 | ★ $36.25 |
| AVG Volume (30 Days) | ★ 9.6M | 1.5M |
| Earning Date | 04-22-2026 | 03-16-2026 |
| Dividend Yield | ★ 3.74% | 2.48% |
| EPS Growth | ★ 17.09 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $16,937,000,000.00 | N/A |
| Revenue This Year | $5.43 | $8.58 |
| Revenue Next Year | $4.52 | $5.60 |
| P/E Ratio | ★ $38.95 | $64.97 |
| Revenue Growth | ★ 12.17 | N/A |
| 52 Week Low | $25.60 | $28.48 |
| 52 Week High | $34.81 | $38.79 |
Technical Indicators
Market Signals| Indicator | KMI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 38.66 |
| Support Level | $30.87 | N/A |
| Resistance Level | $33.02 | $31.36 |
| Average True Range (ATR) | 0.80 | 0.47 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 55.88 | 8.59 |
Price Performance
Historical ComparisonAbout KMI Kinder Morgan Inc.
Kinder Morgan operates natural gas, crude oil, and refined products pipelines connecting producing regions to demand centers. It is principally involved in the gathering, storage, and transmission of natural gas across the continental United States. It also operates distribution centers for refined products along with the largest fleet of Jones Act-compliant tankers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.